6
23
Ṁ331Ṁ350
2027
20%
chance
1D
1W
1M
ALL
Resolves YES if the FDA grants full approval for the commercial sale of any mRNA-based vaccine for the treatment of glioblastoma in the United States before January 1, 2028. This does not include emergency use authorization or other forms of limited authorization. Resolves NO otherwise.
Get Ṁ600 play money
Sort by:
Some promising results in the first small-scale human clinical trial:
https://medicalxpress.com/news/2024-05-mrna-cancer-vaccine-triggers-fierce.html
Related questions
Will FDA approve any mRNA vaccine against melanoma before 2028?
49% chance
Will FDA approve any mRNA vaccine against malaria before 2028?
45% chance
Will FDA approve any mRNA vaccine against non-small-cell lung carcinoma before 2028?
38% chance
Will FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028?
63% chance
Will the FDA approve a disease-modifying treatment for Parkinson's disease before 2029?
59% chance
Will FDA approve any mRNA vaccine against squamous cell carcinoma before 2028?
35% chance
Will FDA approve any mRNA vaccine against lymphoblastic leukemia before 2028?
34% chance
Will FDA approve any mRNA vaccine against any strain of influenza before 2028?
78% chance
Will FDA approve any mRNA vaccine against myeloid leukemia before 2028?
28% chance
Will FDA approve any mRNA vaccine against mesothelioma before 2028?
33% chance